On February 20, 2025, Robert Mcnamara, a Director at AVITA Medical Inc (RCEL), purchased 10,000 shares of the company, as reported in the SEC Filing. Following
We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
Commercial Revenue: $18.4 million for Q4 2024, a 30% increase compared to Q4 2023.Full-Year Revenue: $64 million for 2024, a 29% increase from $49.8 million in
Feb 14, 2025 / 09:30PM GMTOperator Good day, and thank you for standing by. Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator
VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ( RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transform
We came across a bullish thesis on AVITA Medical, Inc. (NASDAQ:RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
Seattle-based biotechnology company Sana Biotechnology, Inc. (SANA) is up over 227 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Wednesday.
Shares of AVITA Medical, Inc RCEL fell sharply in t...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...
Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.